+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ten years survival of FIGO stage IIIC epithelial ovarian cancer cases due to lymph node metastases only



Ten years survival of FIGO stage IIIC epithelial ovarian cancer cases due to lymph node metastases only



European Journal of Gynaecological Oncology 33(6): 615-616



In this paper the authors have analyzed the long-term survival of women with Stage III ovarian cancer due to lymph node metastasis. This retrospective study included 27 patients with FIGO Stage IIIC epithelial ovarian carcinoma due to lymph node metastases observed consecutively at the Mangiagalli Clinic of Milan from 1982 to 2008. Two cases had Fallopian tube carcinoma. A total of ten recurrences were observed. Median time to recurrence was 158 months. The five-year disease-free survival (DFS) was 57.7%. The ten-year corresponding value was 53.2%. Median survival time was 158 months, with median follow-up time of 169 months. The five-year (overall survival) OS rate was 77.1%; the ten-year rate was 55.4%. Women with ovarian cancer Stage IIIC due to nodal involvement have a five-year OS of about 80% and a ten-year OS of about 50%.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056144978

Download citation: RISBibTeXText

PMID: 23327056


Related references

The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer. International Journal of Gynecological Cancer 14(1): 51-56, 2004

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. Journal of Gynecologic Oncology 19(4): 223-228, 2008

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network. Annals of Surgical Oncology 23(4): 1279-1286, 2016

ADVANCED STAGE OF EPITHELIAL OVARIAN CANCER (II-IV FIGO STAGE). THE ROLE OF LYMPH NODE DISSECTION: IGCS-0019 Ovarian Cancer. International Journal of Gynecological Cancer 25(Suppl. 1): 53, 2015

Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study. Oncotarget 7(7): 7952-7959, 2016

Survival impact of complete cytoreductive surgery in the primary management of FIGO stage IIIC, high-grade, epithelial ovarian cancer. Journal of Clinical Oncology 26(15_Suppl): 16551-16551, 2016

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecologic Oncology 99(3): 689-695, 2005

The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer. Archives of Gynecology and Obstetrics 280(6): 939-944, 2009

Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival. European Journal of Gynaecological Oncology 37(3): 305-311, 2016

In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival. Virchows Archiv 466(5): 571-580, 2015

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer. Obstetrics and Gynecology International 2015: 464123, 2015

Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study. Annals of Surgical Oncology 24(9): 2720-2726, 2017

Lymph node-positive stage IIIC ovarian cancer: a separate entity?. International Journal of Gynecological Cancer 19(Suppl. 2): S18-S20, 2009

Incidence of Lymph Node Metastases in Apparent Early-Stage Low-Grade Epithelial Ovarian Cancer: A Comprehensive Review. International Journal of Gynecological Cancer 26(8): 1407-1414, 2016

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer. Journal of Oncology 2014: 312193, 2014